semaglutide fda Clears For Cardiac Risk Reduction in Diabetic Patients Doctors Petition FDA for Labeling

10.3324/haematol.2018.213207 Haematologica 9 BerthautI.GuignedouxG.Kirsch-NoirF.de LarouziereV.RavelC.BachirD.et al (2008)

A Phase I study indicates the treatment is safe and well-tolerated

The Canadian government has actively supported the adoption of these therapies through initiatives like the Diabetes 360 strategy, which aims to reduce the national diabetes burden by improving access to innovative treatments

60 It follows that prevention of obesity remains the most important goal of the PWS therapeutic strategy

Women of childbearing potential should be aware that tirzepatide may reduce the effectiveness of oral hormonal contraceptives, particularly after initiation or dose increases, and should consider using non-oral or additional contraceptive methods